Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Aurobindo Pharma clears FTC hurdle for $250m Lannett acquisition Aurobindo Pharma clears the FTC hurdle for its $250 million Lannett deal. Explore divestitures, US expansion, integration risks and stock outlook. byVenkateshJune 19, 2026